John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$267M |
| 2 |
Amazon
AMZN
|
+$243M |
| 3 |
Applied Materials
AMAT
|
+$242M |
| 4 |
Airbnb
ABNB
|
+$221M |
| 5 |
Meta Platforms (Facebook)
META
|
+$213M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$262M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$259M |
| 3 |
Wells Fargo
WFC
|
+$238M |
| 4 |
Broadcom
AVGO
|
+$233M |
| 5 |
Applovin
APP
|
+$225M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.95% |
| 2 | Healthcare | 13.56% |
| 3 | Financials | 11.46% |
| 4 | Consumer Discretionary | 9.22% |
| 5 | Industrials | 9.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SOL
3026
DELISTED
Emeren Group
SOL
| $24.2K | ﹤0.01% |
11,900
+1,000
| +9% | +$2.21K |
|
|
TRVG
3027
trivago
TRVG
$380M
| $23.2K | ﹤0.01% |
10,656
-7,546
| -41% | -$14.6K |
|
3028
Zhongchao
ZCMD
$5.7M
| $22.7K | ﹤0.01% |
+19
| New | +$23K |
|
3029
Pixelworks
PXLW
$41.3M
| $22.6K | ﹤0.01% |
2,579
-2,253
| -47% | -$20.4K |
|
|
FRGE
3030
DELISTED
Forge Global Holdings
FRGE
| $22.6K | ﹤0.01% |
+1,615
| New | +$26.6K |
|
3031
La Rosa Holding
LRHC
$1.83M
| $22.2K | ﹤0.01% |
+3
| New | +$17K |
|
3032
Arena Group
AREN
$46.2M
| $21.8K | ﹤0.01% |
+16,267
| New | +$18.2K |
|
3033
Taysha Gene Therapies
TSHA
$1.96B
| $21.3K | ﹤0.01% |
+12,300
| New | +$25.5K |
|
3034
Cellectar Biosciences
CLRB
$24M
| $21.3K | ﹤0.01% |
+2,371
| New | +$110K |
|
|
FLYE
3035
Fly-E Group
FLYE
$2.66M
| $21.3K | ﹤0.01% |
253
| – | – |
|
3036
Goldgroup Mining
GORO
$270M
| $21.1K | ﹤0.01% |
91,796
-1,529
| -2% | -$349 |
|
3037
SurgePays
SURG
$4.06M
| $21.1K | ﹤0.01% |
+11,849
| New | +$20.9K |
|
|
SY
3038
So-Young International
SY
$241M
| $20.3K | ﹤0.01% |
24,491
-181
| -0.7% | -$164 |
|
3039
Seres Therapeutics
MCRB
$46.8M
| $20.3K | ﹤0.01% |
+1,221
| New | +$19.8K |
|
3040
FibroBiologics
FBLG
$8.72M
| $20.1K | ﹤0.01% |
503
-20
| -4% | -$1.07K |
|
3041
Outlook Therapeutics
OTLK
$146M
| $20K | ﹤0.01% |
+10,591
| New | +$43.6K |
|
|
LFLY
3042
DELISTED
Leafly Holdings, Inc. Common Stock
LFLY
| $19.9K | ﹤0.01% |
+12,707
| New | +$21K |
|
|
LNAI
3043
Lunai Bioworks
LNAI
$9.93M
| $19.8K | ﹤0.01% |
297
+16
| +6% | +$1.06K |
|
3044
Aethlon Medical
AEMD
$1.89M
| $19.4K | ﹤0.01% |
56
+17
| +44% | +$2.88K |
|
3045
PEDEVCO
PED
$178M
| $18.8K | ﹤0.01% |
1,210
-2
| -0.2% | -$35 |
|
3046
GrafTech
EAF
$170M
| $17.9K | ﹤0.01% |
+1,033
| New | +$19.2K |
|
|
RPTX
3047
DELISTED
Repare Therapeutics
RPTX
| $17.6K | ﹤0.01% |
13,467
-41,348
| -75% | -$123K |
|
3048
Garden Stage Ltd
GSIW
$23.6M
| $16.8K | ﹤0.01% |
+126
| New | +$24.7K |
|
|
OMGA
3049
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
| $16.2K | ﹤0.01% |
21,744
-59,347
| -73% | -$59.1K |
|
|
NKGN
3050
DELISTED
NKGen Biotech, Inc. Common Stock
NKGN
| $14.6K | ﹤0.01% |
+22,356
| New | +$9.12K |
|
Similar funds
John Overdeck's Q4 2024 Portfolio in Review
As of Q4 2024, John Overdeck held 3,590 positions worth $45.9B, up 0.48% from $45.6B the previous quarter. Its ten largest holdings account for 7.2% of the portfolio.
John Overdeck withdrew a net $1.69B in Q4 2024, closing 427 positions and reducing 1,388 holdings. Its most notable exit was iShares MSCI Emerging Markets ETF, an estimated $184M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.
Against the trend, John Overdeck opened a new position in Intel worth $237M.
- John Overdeck's largest Q4 2024 buy was Intel: 11,843,258 shares worth $237M.
- John Overdeck added most to Amazon in Q4 2024, an estimated $243M increase.
- John Overdeck's biggest Q4 2024 reduction was Micron Technology, cutting an estimated $262M.
- John Overdeck fully exited iShares MSCI Emerging Markets ETF in Q4 2024, selling an estimated $184M.
- John Overdeck's ten largest holdings make up 7.2% of its $45.9B portfolio in Q4 2024.
- John Overdeck opened 477 new positions and closed 427 in Q4 2024.
- John Overdeck's portfolio value rose 0.48% quarter-over-quarter to $45.9B.
Based on Two Sigma Investments's 13F filing for Q4 2024, filed 14 Feb 2025.